Hypothesis: Real-time AI-driven feedback that prompts individualized behavioral corrections when wearable metrics deviate from personal baselines will produce measurable improvements in objective metabolic and cardiovascular health markers in healthy adults, whereas sham feedback will not.

Mechanistic basis: Continuous glucose monitors and HRV sensors capture high‑frequency physiological noise that reflects immediate autonomic and metabolic responses to meals, activity, and stress. Prior work shows heart‑rate monitoring is rated most useful for fitness and recovery insights【Heart rate monitoring rated most useful in 2023 surveys for fitness and recovery insights](https://www.jmir.org/2025/1/e56251/), yet no direct evidence links self‑tracking to objective health gains in healthy cohorts【No direct evidence exists that self-tracking improves objective health outcomes in healthy individuals; benefits remain largely perceptual, such as self-reported diet or sleep improvements](https://www.jmir.org/2021/9/e25171/). A 2021 systematic review of 67 quantified‑self studies urges n‑of‑1 designs to test how personal baselines and fluctuations affect health【A 2021 systematic review of 67 studies on quantified self-tracking explicitly calls for n-of-1 experimental designs to understand how personal baselines and fluctuations—wearables capture continuously—impact health](https://www.jmir.org/2021/9/e25171/)**, establishing the methodological gap this hypothesis addresses.

We propose that an AI algorithm, trained on each user’s baseline streams, detects statistically significant excursions (e.g., post‑prandial glucose >1 SD above individual mean or nightly HRV drop >1.5 SD) and issues a micro‑intervention—such as a 2‑minute paced breathing bout or a brief walk—within five minutes. The vagal activation from paced breathing is known to suppress hepatic glucose output and improve peripheral insulin uptake, while light muscle contraction enhances glucose translocation independent of insulin. By repeatedly coupling deviation detection with corrective action, the system should tighten homeostatic control, lowering average glucose variability and elevating nocturnal HRV, which in turn reduces sympathetic drive and blood pressure over weeks.

Testable prediction: In a randomized crossover n‑of‑1 trial, 30 healthy adults will wear a CGM, HRV chest strap, and sleep tracker for eight weeks. Weeks 1‑2 establish baselines; weeks 3‑6 participants receive either AI‑guided prompts or sham prompts (randomized order, two‑week washout). Primary outcomes are change in fasting glucose, HbA1c, systolic blood pressure, and 24‑hr glucose SD compared to baseline. Secondary outcomes include self‑reported stress and sleep quality. If AI‑guided weeks produce a statistically significant reduction in fasting glucose (≥5 mg/dL) and HbA1c (≥0.2 %) and systolic BP (≥4 mmHg) relative to sham, the hypothesis is supported; absence of such differences falsifies it.

This framework moves beyond perceptual benefits by linking individualized data streams to mechanistically grounded, AI‑mediated behavior change, directly testing whether closing the loop on personal variability yields objective health gains in a population previously shown to lack evidence of benefit from passive self‑tracking.